Analyze the Medtronic 670g pump on glycemic control
An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on glycemic control , quality of life, and compliance
Study Type
OBSERVATIONAL
Enrollment
100
Metabolic Research Institute
West Palm Beach, Florida, United States
RECRUITINGGlycemic control while using the Medtronic MiniMed 670g system
HbA1c, fructosamine, and glycomark will be compared between the participants last visit on previous insulin therapy and the last visit using the pump
Time frame: through study completion, an average of 1 year.
Efficacy of Quality of Life and satisfaction while using the MiniMed 670g system
Diabetes Treatment Satisfaction, Diabetes-dependent Quality of Life, and Pump QOL vs Previous Therapy Questionnaires will be completed by each study participant
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.